Manufacturing site not PQ-ready during inspection preparation – preventing PQ suspension


Published on 29/01/2026

Ensuring Manufacturing Sites Are Prepared for PQ Inspections: A Playbook

In the pharmaceutical industry, the inability of a manufacturing site to meet prequalification (PQ) standards prior to inspection can lead to significant setbacks, including the suspension of critical processes. This situation is particularly fraught with risks, as it can lead to costly delays and reputational damage. The goal of this playbook is to guide professionals through practical steps to ensure compliance and readiness for PQ inspections, ultimately reducing the risk of suspension.

For a broader overview and preventive tips, explore our WHO Prequalification (PQ).

By systematically addressing symptoms, identifying potential causes, and implementing robust controls, companies can effectively navigate the complexities of regulatory expectations and maintain an inspection-ready status. After digesting this guide, readers will possess the tools to enhance their inspection preparedness and mitigate the possibility of compliance failures.

Symptoms/Signals on the Floor or in the Lab

Effective identification of warning signs is critical to maintaining

compliance with PQ standards. Here are key symptoms indicative of a lack of PQ readiness:

  • Inconsistent Batch Records – Documentation discrepancies can indicate failures in adherence to protocols.
  • Frequent Deviations – An uptick in deviations may suggest underlying quality issues that require immediate attention.
  • Exceeding Trending Limits – Outliers in process data can be a symptom of equipment malfunction or incorrect methodology.
  • Improper Storage Conditions – Any deviations in storage temperature or humidity can compromise raw materials and products.
  • Employee Complaints or Anomalies – Reports of unsatisfactory conditions or process inconsistencies should be scrutinized.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the potential causes behind the symptoms is vital for a focused response. The following categories can help identify where issues may arise:

  • Materials: Raw material quality deviations or expirations. Review supplier certifications and batch integrity.
  • Method: Inadequate or outdated Standard Operating Procedures (SOPs) can lead to misinformation. Ensure SOPs align with regulatory updates.
  • Machine: Equipment breakdowns or suboptimal performance can lead to contamination or incorrect dosages. Regular maintenance and calibration are vital.
  • Man: Human error due to insufficient training or oversight may result in protocol deviations. Invest in continuous training sessions.
  • Measurement: Use of unvalidated methods or sensors that have drifted can result in false data. Use control charts to monitor measurement systems.
  • Environment: Factors such as dust, temperature, and humidity can affect production quality. Regular environment monitoring should be in place.
Pharma Tip:  CAPA effectiveness doubted during inspection preparation – preventing PQ suspension

Immediate Containment Actions (first 60 minutes)

When symptoms surface, a swift containment action plan should be initiated. This includes:

  1. Cease Operation: Stop relevant processes immediately to prevent further issues.
  2. Gather Key Personnel: Assemble a team comprising QA, QC, Engineering, and Production staff for immediate assessment.
  3. Initiate Log Entry: Document the time of detection, action taken, and personnel involved in the initial investigation.
  4. Assess Impact: Conduct a preliminary analysis to determine the extent of the issues, focusing on recent batches.
  5. Implement Temporary Controls: Execute temporary measures, such as additional inspections or controls, to mitigate risks.

Investigation Workflow (data to collect + how to interpret)

A comprehensive investigation workflow enhances the understanding of root causes:

  1. Data Collection: Collect data on batch records, environmental conditions, and equipment performance.
  2. Interview Personnel: Speak with operators and supervisors to gather qualitative data on symptoms.
  3. Analyze Historical Trends: Review historical quality metrics and any previous corrective actions.
  4. Reporting Metrics: Create both quantitative and qualitative reports for the investigation team.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Identifying root causes effectively can prevent recurrences. Here are three essential tools:

  • 5-Why Analysis: Best used for straightforward problems that can be quickly addressed. Ask ‘why’ multiple times (typically five) until the root is identified.
  • Fishbone Diagram: Ideal for complex issues where multiple factors could be the cause. It visually categorizes potential causes by type.
  • Fault Tree Analysis: Best applied in situations where there is complex interaction among multiple failures. This technique allows for a detailed breakdown of system failures.
Pharma Tip:  PQ dossier deficiency during dossier submission – PQ assessment risk and mitigation

CAPA Strategy (correction, corrective action, preventive action)

Establishing a robust CAPA strategy involves several components:

  • Correction: Address immediate issues to eliminate the symptoms reported. For example, rerun failed batches if they meet standards after review.
  • Corrective Action: Modify processes and SOPs to prevent recurrence. Involve affected departments in crafting solutions.
  • Preventive Action: Implement proactive measures such as enhanced training and audit schedules to ensure sustained compliance.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

A well-defined control strategy aids in long-term compliance:

  • Statistical Process Control (SPC): Leverage SPC to identify trends before they become critical issues. Regularly review control charts.
  • Sampling Plans: Implement structured sampling plans that align with regulatory requirements for raw materials and products.
  • Alarm Systems: Employ alarm systems to alert operators to deviations, thus allowing for immediate corrective actions.
  • Verification: Regularly verify manufacturing and testing procedures through internal audits and management reviews.

Validation / Re-qualification / Change Control impact (when needed)

Changes in processes or equipment may require validation or re-qualification. Here’s what to consider:

  • Validation: Confirm that all methods, processes, and equipment consistently produce outcomes meeting specifications and quality attributes.
  • Re-qualification: Continuously assess equipment based on defined criteria after significant changes or if defeat occurs.
  • Change Control: Implement a robust change control process that requires all changes to be documented and evaluated for impact on product quality.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

For successful inspections, the following documentation must be accessible:

Related Reads

  • Records: Maintain thorough batch production and QC testing records.
  • Logs: Keep equipment calibration and maintenance logs current and accurate.
  • Batch Documentation: Ensure batch documentation aligns with current regulatory standards and is readily available.
  • Deviation Management: Document all deviations with corrective action taken, ensuring it complies with both regulations and internal SOPs.
Pharma Tip:  Stability data gaps during inspection preparation – documentation gaps reviewers flag

FAQs

What does PQ readiness mean?

PQ readiness indicates the manufacturing site’s compliance with WHO standards necessary for the production of safe and effective medicines.

How do you ensure compliance with GMP?

Regular audits, staff training, and documentation practices aimed at continuous improvement ensure compliance with GMP.

What documentation is required for PQ inspection?

Adequate batch records, validation documents, SOPs, and equipment calibration logs should be prepared and made accessible for inspection.

What are the key components of an effective CAPA?

An effective CAPA includes identifying the root cause of deviations, implementing corrective measures, and applying preventive actions.

How often should control parameters be reviewed?

Control parameters should be reviewed regularly, with documentation supporting these checks available for inspections.

What is the importance of real-time monitoring?

Real-time monitoring helps quickly identify deviations, allowing for immediate action before they escalate into significant issues.

What actions should be taken if a deviation occurs during production?

Cease production immediately, assess the impact, initiate a thorough investigation, and document findings.

What role does employee training play in PQ readiness?

Continuous employee training ensures that all staff are aware of compliance standards, procedures, and the importance of their roles in ensuring quality.

How do you prepare for an FDA or EMA inspection?

Preparation involves reviewing compliance history, ensuring documentation is complete and accurate, and conducting mock inspections to identify potential issues.

Why is change control important?

Change control is vital to manage any changes to processes, equipment, or systems that could affect product quality, ensuring they are evaluated and documented properly.

When should equipment be re-qualified?

Equipment should be re-qualified any time there is a significant change in process, after maintenance that exceeds normal limits, or when expected performance falls below standards.

Where can I find regulatory guidance on PQ compliance?

For comprehensive guidelines, refer to official documents provided by WHO, FDA, and EMA.